Press Release

United States Humanized Mice Model Market to Grow with a CAGR of 6.12% through 2028

Increasing number of research activities involving humanized models and increasing Number of R&D activities in pharmaceutical & biotechnology companies is expected to drive the United States Humanized Mice Model Market growth in the forecast period, 2024-2028. 

According to TechSci Research report, “United States Humanized Mice Model Market –Industry Size, Share, Trends, Competition Forecast & Opportunities, 2018-2028F”, the United States Humanized Mice Model Market stood at USD 36.31 Million in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 6.12% through 2028. The United States Humanized Mice Model Market is driven by several key factors. The escalating prevalence of diseases such as cancer and diabetes, coupled with the increasing demand for personalized medicine, are among the major drivers.

Further, advancements in genetic engineering technologies and the growing focus on human microbiome research are propelling growth in this market. Additionally, the expansion of biomedical research requiring humanized mice models contributes to the market's robust momentum. It's important to note that regulatory approvals and ethical considerations also influence the dynamics of the market.

The United States Humanized Mice Model Market refers to a thriving and innovative business sector that revolves around the utilization of laboratory mice that have been "humanized". These extraordinary mice are not just your ordinary rodents; they are genetically modified to possess functional human genes, cells, or tissues, making them invaluable research tools in the field of biomedical research. Their unique genetic makeup allows scientists and researchers to gain deeper insights into various areas of study, including immunology, oncology, infectious diseases, and autoimmunity.

In this expansive market, there are various aspects to consider. Firstly, it involves the specialized breeding and distribution of these incredible mice. Skilled professionals work tirelessly to ensure the production of high-quality humanized mouse models that meet the stringent standards required for scientific research. Additionally, the market encompasses the provision of essential services and products necessary for the maintenance and utilization of these mice in research settings. From state-of-the-art housing facilities to specialized diets and medical care, every aspect is carefully designed to ensure the well-being and optimal performance of these unique research tools.

As the demand for these humanized mouse models continues to grow, the United States Humanized Mice Model Market thrives by meeting the evolving needs of researchers and scientists dedicated to pushing the boundaries of biomedical knowledge. The market continuously adapts to the latest advancements in genetic engineering and research methodologies, ensuring that scientists have access to the most cutting-edge tools and resources to further their investigations. By fostering collaboration between academia, industry, and research institutions, this market plays a pivotal role in driving scientific breakthroughs and advancing our understanding of complex diseases and biological processes.

The United States Humanized Mice Model Market represents a dynamic and essential component of the biomedical research landscape. Through the utilization of these genetically modified mice, researchers are able to delve deeper into the intricacies of human biology, uncovering vital insights that have the potential to transform healthcare and improve the lives of millions. With the continuous expansion of knowledge and technological advancements, this market is poised to play an even more significant role in shaping the future of biomedical research and innovation.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Humanized Mice Model Market.”


The United States Humanized Mice Model Market is segmented into type, application, end user, regional distribution, and company.

Based on end user, Pharmaceutical and biotechnology companies are projected to dominate the United States Humanized Mice Model Market. This can be attributed to their extensive utilization of these models in various drug discovery and development processes. These companies not only recognize the importance of humanized mice models but also make significant investments in research and development (R&D) activities to enhance their understanding and application. The ever-evolving landscape of genetic engineering has further revolutionized the usage of humanized mice models. With advancements in technology, researchers now have more precise and efficient tools to study and manipulate these models. This has contributed to their increased adoption within the pharmaceutical and biotechnology industry, as they offer a more accurate representation of human biology and enable more accurate prediction of drug efficacy and safety.

Furthermore, the growing adoption of humanized mice models by pharmaceutical and biotechnology companies reflects the industry's commitment to advancing drug discovery and development. By leveraging these models, researchers can gain valuable insights into human physiology and pathology, leading to the development of more effective and targeted therapies. The ability to mimic human physiological responses and diseases in these models allows for the identification of potential drug candidates with higher success rates and fewer adverse effects. As the field of genetic engineering continues to evolve, we can expect even greater advancements in the utilization of humanized mice models, further shaping the future of drug development and personalized medicine. The integration of cutting-edge technologies, such as CRISPR-Cas9, has opened up new avenues for precise genetic modifications in these models, enabling researchers to study specific disease mechanisms and test targeted therapeutics.

Based on region, the North-East region of the United States is poised to lead the Humanized Mice Model Market due to several factors. This region is renowned for its concentration of world-class research institutions and biotechnology companies that heavily rely on these models for cutting-edge research and development. With their state-of-the-art facilities and brilliant minds, these institutions and companies drive the advancement of humanized mice models, pushing the boundaries of biomedical science. The region's robust funding landscape plays a significant role in propelling this market forward. Notably, the North-East benefits from substantial venture capital investment, which fuels innovation and supports the growth of biotech companies specializing in humanized mice models. Additionally, government funding for biomedical research in the region is both substantial and consistent, providing the necessary resources for groundbreaking studies and discoveries.

Lastly, the presence of a vibrant biotech ecosystem in the North-East foster’s collaboration, innovation, and rapid market uptake of advanced technologies like humanized mice models. The region serves as a hub for scientific and entrepreneurial talent, attracting researchers, experts, and investors from around the world. This collaborative environment, combined with the availability of cutting-edge infrastructure and resources, creates an ideal breeding ground for the development and utilization of humanized mice models in various scientific fields.


Major companies operating in the United States Humanized Mice Model Market are:

  • Charles River Laboratories International, Inc.
  • The Jackson Laboratory
  • Taconic Biosciences Inc.
  • Hera BioLabs
  • Ingenious Targeting Laboratory Inc.
  • Champions Oncology, Inc.
  • Yecuris Corporation


Download Free Sample Report

Customers can also request 10% free customization on this report.


“The future of the humanized mice model market in the United States is poised for significant growth. This expansion is driven by the increasing demand for advanced biomedical research in various fields, including oncology and infectious diseases. As the need for personalized medicine continues to grow, the development of humanized mice models becomes even more crucial. Innovations in genetic engineering technology are expected to play a pivotal role in refining these models. By incorporating cutting-edge genetic modifications, researchers can enhance the simulation of human immune responses and disease progression, making these models even more accurate and reliable. As the scientific community continues to address these concerns and develop alternative methods, the future of humanized mice models remains promising, offering immense potential for advancing biomedical research and improving human health.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

United States Humanized Mice Model Market By Type (Genetic Humanized Mice Model, Cell-based Humanized Mice Model), By Application (Oncology Studies, Immunology and Inflammation Studies, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), By Region, Competition, Forecast and& Opportunities, 2018-2028F”, has evaluated the future growth potential of United States Humanized Mice Model Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Humanized Mice Model Market.



Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]


Relevant News